It has been reported that CXCL5 expression has been used as a prognosis predictor that is related to poor prognosis in many cancers, such as prostate cancer, endometrial cancer, hepatocellular carcinoma, and pancreatic cancer31,32. This evidence concerns the gene CXCL5 and hepatocellular carcinoma.